Oral hypoglycemic drugs, sulfonylurea and biguanide, have been widely employed and they have played an important role in the treatment for diabetes mellitus. In 1970 and 1975, however, the University Group of Diabetic Program (UGDP) in the United States reported that an increased death rate due to cardio vascular lesion was observed in the group treated with tolbutamide or phenformin compared with those treated with diet alone or insulin. Since then a lot of reports concerning this problem were published by various researchers (Paasikivi 1970; Keen 1971; Friedman et al. 1971; Boyle et al . 1972; Haaden et al. 1972; Seltzer 1972; Feldman et al. 1973 ). In 1972, we performed a statistical study as to the effect of oral hypoglycemic agents upon the vascular complications of diabetes mellitus (Maruhama et al. 1972) . From the observation it was suggested that the deaths due to cardiovascular complications were rare in diabetic patients receiving hypoglycemic agents in Japan, differing from the report by the UGDP . For the assessment of the relationship between the development of cardiovascular com plications and the oral hypoglycemic agents, further studies should be carried out on the large scale of patients who were treated for a long time , more than 5 years, as indicated by the report of the UGDP (1970a, b) . However, the previous study from our Department included a small number of diabetics who were observed for a long period. Therefore, in order to investigate the effect of the treatment with hypoglycemic sulfonylureas upon the cardiovascular complications , a retrospective study was performed in diabetic patients who had been treated in our diabetic clinic for more than eight years . •õ Numbers in parentheses represent the percentage. than 50%). To compare quantitatively the changes in ECG and the retinal lesion, grada tion was performed based on the Minnesota code (Blackburn et al. 1960 ) and Scott's classification (1957), respectively (Tables 4 and 5) . In order to investigate the correlation between the clinical status and changes in cardiovascular as well as retinal lesions, clinical variables during eight years were summarized as follows: body weight, FBG and serum lipids, the mean value of each variant during 8 years; hypoglycemia, albuminuria or ketonuria, the mean value of each point during 8 years; and blood pressure, a mean blood pressure obtained from the formula, D+(S-D)/3, where D and S are diastolic and systolic blood pressures, respectively. From the mean pressure the gradation was defined as follows: 0, less than 109; 1, 110 to 126; 2, 127 to 146; and 3, 147 to 166 mmHg (Masuyama 1970) . Correlation between variables and stepwise multiple-regression analyses were performed on an NEA 2200-Model 500 Computer at Tohoku University Computer Center.
SUBJECTS AND METHODS
In addition, another retrospective study was performed concerning the type of treatment, duration of the disease and cause of death in 152 diabetic patients who died between 1961 and 1976. Here patients with diabetic glucose tolerance secondary to other diseases were also excluded.
In the present study the mean values and standard errors were calculated. The comparison of the percentages in each group was carried out by the chi square test, and that of the mean values by Student's t-test. In group I as shown in Table 7 , a significant correlation was observed between age at the first visit and blood pressure (r=0.38). There was a significant corre lation between FBG at the first visit and control status of FBG as well as body weight (r=0.46 and r=0.32, respectively). Correlation coefficients between control status of blood glucose and body weight and between serum phospholipid and serum cholesterol were 0.32 and 0.70, respectively. However, no correlation was observed between other variables and the development of retinopathy as well as the abnormalities in ECG.
The correlation coefficients in group ‡U are presented in Table  8 . There was The abbreviations are similar to those in Table 7 . 
Statistical analyses in 152 deaths
Since an increased mortality in the patients treated with tolbutamide was the most conspicuous problem in the UGDP report, statistical analyses were performed with great interest. The total number of diabetic patients who attended our diabetic clinic during the period from January 1961 to August 1976 amounted 2100. Among these patients, 775 diabetics were classified into the patient group treated with diet alone (group A), 748 patients into the group treated with oral hypoglycemic agents (group B) and 481 into the group with insulin injection (group C). The percentages of patients died were 8.9, 3.5 and 11.9 for groups A, B and C, respectively. There was a highly significant difference in the mortality among the three diabetic groups (x2=30.63, p<0.001): the mortality was highest in group C and lowest in group B.
The cumulated death numbers in each group are presented in Fig. 7 . Deaths in the group treated with diet alone exceeded those in the other groups throughout 15 years. The death number was lowest in the group treated with sulfonylurea and that of the group treated with insulin was distributed between the other two groups . This figure was similar to that reported in 1972 from our Clinic (Maruhama et al. 1972) but different markedly from the results by the UGDP research (1970a, b). The causes of death are shown in Table 12 . In group A, 25 out of 69 patients (36.2%) died of malignant neoplasma, 14 (20.3%) of liver diseases and 9 (13%) of cerebral vascular diseases. Only 2 patients died of cardiac insufficiency. In group B, 11 out of 26 patients (42.3%) died of cerebral vascular accidents, 3 (11.5%) of renal diseases, 3 (11.5%) of myocardial infarction and one of cardiac insufficiency. In group C, 18 out of 57 patients (31.6%) died of renal diseases, 12 (21.1%) of infectious diseases, 8 (14.0%) of malignant neoplasma, 3 (5.3%) of myocardial infarction and 2 (3.5%) of cardiac insufficiency. In total, 33 patients (21.7%) died of malignant neoplasma, 25 (16.4%) of renal diseases and 24 (15.8%) of cerebral vascular accidents. Myocardial infarction was recognized in 6 patients (3.9%) and cardiac insufficiency in 5 patients (3.3%). At any rate, however, the percentage of deaths from heart diseases was very low in the present study. Furthermore, no significant difference was observed in the death rate of cardiac events between the three diabetic groups (X2=4.65, p<0.1).
DISCUSSION
In order to investigate the effect of drugs, various approaches have been employed. Among them a controlled and prospective study on a large scale seems to be the most complete in a sense of statistical assessment at the moment as reported by the UGDP (1970a, b) . In clinical practice for diabetes mellitus, however, the decision of what kind of treatment should be used to an individual patient is made by different protocols in various clinics. In our diabetic clinic, the type of the treatment for diabetes mellitus has been determined by the method described previously (Ohneda et al. 1975 ). In the present study, retrospective statistical analyses were performed on three diabetic groups treated with different methods for more than eight years. Therefore, the baseline characteristics of the groups were not identical. For example, significant differences were observed in age distribution, FBG at the first visit, body weight index and the percentage of the patients complicated with diabetic retinopathy. To the contrary, there were no significant differences in sex distribution, serum lipids and abnormal ECG at the first visit among the three diabetic groups.
As shown in Fig. 1 The principal conclusion of the UGDP (1970a, b) was the excess cardiovascular mortality observed in the tolbutamide treated group. Therefore, we are particularly interested in the changes in ECG of the three diabetic groups during eight years of observation. In the present study, no significant difference was noticed among the three diabetic groups, as far as abnormalities in ECG at the eighth year and deterioration of ECG findings were concerned. According to the UGDP study (1976) "the percentage of patients identified with fatal or non-fatal myocardial infarction was approximately the same in all treatment groups." From the present study it was difficult to obtain any specific factors which correlate with the deterioration of ECG finding. Although the inotropic action of sulfonylurea has been reported (Lasseter et al. 1972), its long-term effect upon myocardium in diabetes mellitus remains to be investigated. small number of patients on this medication . The mortality, 152 deaths in 2100 diabetics (7.2%), is comparable to the statistical results from the UGDP study 1970a, b). The death rates were 8.9% in the group treated with diet alone (group A), 3.5% in the group with sulfonylurea (group B) and 11 .9% in the group with insulin (group C), indicating highly significant differences in the mortality among the three diabetic groups. As shown in Fig. 7 , cumulative death numbers in groups A and C were larger than that in group B, differing from the report of the UGDP (1970). In the present study, malignant neoplasma was the most frequent cause of death, followed by renal disease or cerebral vascular accidents (CVA). These figures differ from the order of the mortality in Japanese population , in which the order is CVA, malignant neoplasma, cardiac death, infection and accident. In our study, only 11 deaths due to myocardial infarction or cardiac insufficiency were observed, and the percentages of deaths due to heart diseases were not signif icantly different in the three diabetic groups (p<0.1). Here, the FBG levels in the three diabetic groups were, in general, well controlled during the period of observation.
There was no significant difference in the percentages of the patients with specified eye events between the four groups in the UGDP study (1970a, b), while a significant difference in the percentages of the patients with diabetic retinopathy was noticed in the present study. In contrast, the percentages of the patients with ischemic heart disease at the eighth year did not differ among the three diabetic groups in our study. Furthermore, the present investigation indicates that cardio vascular mortality did not increase in the group treated with sulfonylurea in comparison with those of the other groups.
Therefore, the results obtained in the present study do not comfirm the conclusion of the UGDP that the treatment with sulfonylurea does increase the cardiovascular mortality (1970a, b) . The different results obtained in the present investigation might derive from the various factors, such as difference in the subjects or race, different grades of diabetes mellitus, difference in the protocol for the treatment with medicine, or in the procedure in the statistical analyses, and so on. Although it is not reasonable to use hypolgycemic drugs without thought ful attention, it should be warranted "to conduct sicentifically adequate studies to justify the continued use of such agents", as stated by the Biometric Committee (1975 
